Lytgobi is an FGFR inhibitor that received accelerated approval in 2022 to treat adults with previously treated, unresectable ...

Five chief creative officers from leading medical marketing agencies weigh in on how the job has changed and where it’s going.

Intelligence Officials Are Grilled After More Signal Texts Are Released The national intelligence director and the C.I.A. chief, both of whom were in the Signal chat, faced lawmakers in the House ...

RAWALPINDI: The Board of Intermediate and Secondary Education (BISE) Rawalpindi on Tuesday caught seven students... Published 26 Mar, 2025 07:01am ...